vs
FEDERAL AGRICULTURAL MORTGAGE CORP（AGM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
FEDERAL AGRICULTURAL MORTGAGE CORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$107.5M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 6.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.1%）
联邦农业抵押贷款公司（又称Farmer Mac）是由美国国会1988年依据《1987年农业信贷法案》设立、由股东持股的联邦特许企业，核心业务是搭建农业不动产及住房抵押贷款的二级市场，提升农业领域的信贷流动性，为农户、牧场主及乡村社区提供长期稳定的信贷支持。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AGM vs RIGL — 直观对比
营收规模更大
AGM
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出15.1%
6.1%
两年增速更快
RIGL
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.5M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 56.3% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 6.1% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $3.69 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGMRIGL
| Q4 25 | $107.5M | $69.8M | ||
| Q3 25 | $104.0M | $69.5M | ||
| Q2 25 | $102.6M | $101.7M | ||
| Q1 25 | $94.3M | $53.3M | ||
| Q4 24 | $101.3M | $57.6M | ||
| Q3 24 | $90.3M | $55.3M | ||
| Q2 24 | $89.9M | $36.8M | ||
| Q1 24 | $93.7M | $29.5M |
净利润AGMRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $55.0M | $27.9M | ||
| Q2 25 | $54.8M | $59.6M | ||
| Q1 25 | $49.7M | $11.4M | ||
| Q4 24 | $56.5M | $14.3M | ||
| Q3 24 | $49.8M | $12.4M | ||
| Q2 24 | $47.1M | $-1.0M | ||
| Q1 24 | $53.7M | $-8.2M |
毛利率AGMRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率AGMRIGL
| Q4 25 | 56.3% | 33.2% | ||
| Q3 25 | 64.1% | 40.9% | ||
| Q2 25 | 63.8% | 60.1% | ||
| Q1 25 | 66.9% | 23.9% | ||
| Q4 24 | 67.5% | 28.9% | ||
| Q3 24 | 69.0% | 25.4% | ||
| Q2 24 | 65.9% | 1.2% | ||
| Q1 24 | 72.8% | -23.6% |
净利率AGMRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 52.9% | 40.2% | ||
| Q2 25 | 53.4% | 58.6% | ||
| Q1 25 | 52.6% | 21.5% | ||
| Q4 24 | 55.8% | 24.9% | ||
| Q3 24 | 55.2% | 22.5% | ||
| Q2 24 | 52.4% | -2.8% | ||
| Q1 24 | 57.4% | -27.9% |
每股收益（稀释后）AGMRIGL
| Q4 25 | $3.69 | $14.11 | ||
| Q3 25 | $4.44 | $1.46 | ||
| Q2 25 | $4.48 | $3.28 | ||
| Q1 25 | $4.01 | $0.63 | ||
| Q4 24 | $4.62 | $0.82 | ||
| Q3 24 | $3.86 | $0.70 | ||
| Q2 24 | $3.68 | $-0.06 | ||
| Q1 24 | $4.28 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $30.8B | $52.5M |
| 股东权益账面价值 | $1.7B | $391.5M |
| 总资产 | $35.4B | $513.6M |
| 负债/权益比越低杠杆越低 | 17.93× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AGMRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | $842.1M | $61.1M | ||
| Q2 24 | $923.0M | $49.1M | ||
| Q1 24 | $745.1M | $49.5M |
总债务AGMRIGL
| Q4 25 | $30.8B | $52.5M | ||
| Q3 25 | $29.2B | $60.0M | ||
| Q2 25 | $28.9B | $60.0M | ||
| Q1 25 | $28.0B | $60.0M | ||
| Q4 24 | $27.5B | $60.0M | ||
| Q3 24 | $27.2B | $60.0M | ||
| Q2 24 | $26.8B | $60.0M | ||
| Q1 24 | $26.8B | $60.0M |
股东权益AGMRIGL
| Q4 25 | $1.7B | $391.5M | ||
| Q3 25 | $1.7B | $117.6M | ||
| Q2 25 | $1.5B | $81.9M | ||
| Q1 25 | $1.5B | $18.6M | ||
| Q4 24 | $1.5B | $3.3M | ||
| Q3 24 | $1.5B | $-14.6M | ||
| Q2 24 | $1.5B | $-29.9M | ||
| Q1 24 | $1.5B | $-31.7M |
总资产AGMRIGL
| Q4 25 | $35.4B | $513.6M | ||
| Q3 25 | $33.4B | $242.5M | ||
| Q2 25 | $33.0B | $206.7M | ||
| Q1 25 | $31.8B | $176.0M | ||
| Q4 24 | $31.3B | $164.0M | ||
| Q3 24 | $30.6B | $139.4M | ||
| Q2 24 | $30.2B | $128.4M | ||
| Q1 24 | $29.8B | $126.5M |
负债/权益比AGMRIGL
| Q4 25 | 17.93× | 0.13× | ||
| Q3 25 | 17.31× | 0.51× | ||
| Q2 25 | 18.70× | 0.73× | ||
| Q1 25 | 18.39× | 3.23× | ||
| Q4 24 | 18.48× | 18.25× | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AGMRIGL
| Q4 25 | $80.1M | $22.0M | ||
| Q3 25 | $74.2M | $24.0M | ||
| Q2 25 | $-47.7M | $30.5M | ||
| Q1 25 | $-49.8M | $-893.0K | ||
| Q4 24 | $612.6M | $14.5M | ||
| Q3 24 | $-44.4M | $21.7M | ||
| Q2 24 | $56.1M | $302.0K | ||
| Q1 24 | $233.3M | $-5.0M |
自由现金流AGMRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $607.4M | — | ||
| Q3 24 | $-44.4M | — | ||
| Q2 24 | $52.6M | — | ||
| Q1 24 | $231.7M | — |
自由现金流率AGMRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 599.8% | — | ||
| Q3 24 | -49.2% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 247.3% | — |
资本支出强度AGMRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 1.7% | — |
现金转化率AGMRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.35× | 0.86× | ||
| Q2 25 | -0.87× | 0.51× | ||
| Q1 25 | -1.00× | -0.08× | ||
| Q4 24 | 10.84× | 1.01× | ||
| Q3 24 | -0.89× | 1.75× | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
